Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug ResponsePing Zhang, Gareth L. Bond, Xuting Wang et al.|Cancer Research|2021Cited by 49
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms <i>In Vitro</i> and in a First-In-Human Phase I Clinical TrialHagen Schwenzer, Sarah P. Blagden, Erica De Zan et al.|Clinical Cancer Research|2021Cited by 44
Heritable genetic variants in key cancer genes link cancer risk with anthropometric traitsMatteo Di Giovannantonio, Gareth L. Bond, Benjamin Harris et al.|Journal of Medical Genetics|2020Cited by 18
Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug responsePing Zhang, Gareth L. Bond, Isaac Kitchen-Smith et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 10
Heritable genetic variants in key cancer genes link cancer risk with anthropometric traitsMatteo Di Giovannantonio, Gareth L. Bond, Benjamin Harris et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 1